PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1%
Fri, 22 Feb

PANACEA BIOTECH has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

PANACEA BIOTECH Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m1,5221,1861,139-4.0%-25.2%
Other incomeRs m19334124.8%118.0%
TurnoverRs m1,5411,2191,180-3.2%-23.4%
ExpensesRs m1,2191,289965-25.1%-20.8%
Gross profitRs m303-578173-42.9%
DepreciationRs m145136136-0.3%-6.4%
InterestRs m2512682825.5%12.5%
Profit before taxRs m-74-948-204
TaxRs m2327270.0%14.7%
Profit after taxRs m-97-975-230
Gross profit margin%19.9-48.715.2
Effective tax rate%-31.4-2.8-13.1
Net profit margin%-6.3-80.0-19.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 25.2% on a year-on-year (YoY) basis. The expenses were down by 20.8% YoY during the same period.
  • The company's operating profit declined by 42.9% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 15.2% in 3QFY19 as against 19.9% in 3QFY18.
  • Depreciation charges declined by 6.4% and finance costs increased by 12.5% YoY, respectively.
  • Other income increased by 118.0% YoY during the quarter.
  • Net profit for the quarter declined by 137.1% YoY. Net profit margins during the quarter declined from -6.3% in 3QFY18 to -19.5% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 4.0% on a quarter-on-quarter (QoQ) basis. The expenses were down by 25.1% QoQ during the same period.
  • The company's operating profit increased by 130.0% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 15.2% in 3QFY19 as against 48.7% in 2QFY18.
  • Net profit for the quarter increased by 76.4% QoQ, while net profit margins increased from -80.0% in 2QFY18 to -19.5% in 3QFY19.

To see how PANACEA BIOTECH has performed over the last eight quarters, please visit here.

PANACEA BIOTECH Share Price Performance

Over the last one year, PANACEA BIOTECH share price has moved up from Rs 323.7 to Rs 181.6, registering a Loss of Rs 142.1 or around 43.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,571.8 (up 0.5%). Over the last one year it has moved down from 13,958.5 to 13,571.8, a gain of 387 points (down 2.8%).

Overall, the S&P BSE SENSEX is up 6.0% over the year.

Current Valuations

At the current price of Rs 181.6, the price to book value (P/BV) ratio of PANACEA BIOTECH stands at 2.2 times.

Equitymaster requests your view! Post a comment on "PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1%". Click here!

  

Related Views on News

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (4QFY18); Net Profit Down 66.5% (Quarterly Result Update)

Jun 20, 2018 | Updated on Jun 20, 2018

For the quarter ended March 2018, PANACEA BIOTECH has posted a net profit of Rs 86 m (down 66.5% YoY). Sales on the other hand came in at Rs 2 bn (up 0.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market(Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys(The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

How to Buy the Best Safe Stocks in 2020(The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Jan 24, 2020 02:15 PM

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH - PFIZER COMPARISON

COMPARE PANACEA BIOTECH WITH

MARKET STATS